Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics01:23

Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics

Respiratory symptoms, such as congestion and cough, commonly accompany respiratory tract conditions. Various medications, such as antitussives, expectorants, and mucolytics, play crucial roles in providing relief.
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla.  Benzonatate operates peripherally within the respiratory tract by anesthetizing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Year in review: "Best" papers in pediatric pulmonary and sleep medicine in 2025.

Paediatric respiratory reviews·2026
Same author

Pressure-enhanced <i>f</i>-electron orbital weighting in UTe<sub>2</sub> mapped by quantum interferometry.

Communications physics·2025
Same author

Enhanced triplet superconductivity in next-generation ultraclean UTe<sub>2</sub>.

Proceedings of the National Academy of Sciences of the United States of America·2024
Same author

Erratum to "The effects of the DASH dietary pattern on clinical outcomes and quality of life in adults with uncontrolled asthma: Design and methods of the ALOHA Trial" [Contemporary Clinical Trials 131 (2023) 107274].

Contemporary clinical trials·2024
Same author

Quasi-2D Fermi surface in the anomalous superconductor UTe<sub>2</sub>.

Nature communications·2024
Same author

The effects of the DASH dietary pattern on clinical outcomes and quality of life in adults with uncontrolled asthma: Design and methods of the ALOHA Trial.

Contemporary clinical trials·2023
Same journal

ASTRA Satellite Symposium -"The Importance of Size".

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same journal

Aerosols for Medical Applications (GAeF Satellite Meeting).

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same journal

Mucus and cilia symposium.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same journal

Aerosol delivery systems.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same journal

Standardization.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
Same journal

Modeling.

Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine·2009
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
07:28

Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

Published on: April 6, 2017

Consensus statement: aerosols and delivery devices

M B Dolovich, N R Macintyre, P J Anderson

    Journal of Aerosol Medicine : the Official Journal of the International Society for Aerosols in Medicine
    |March 21, 2009
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
    04:22

    Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

    Published on: March 30, 2017

    Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies
    08:33

    Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies

    Published on: April 12, 2022

    Related Experiment Videos

    Last Updated: Jun 24, 2026

    Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
    07:28

    Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System

    Published on: April 6, 2017

    Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals
    04:22

    Disposable Dosators for Pulmonary Insufflation of Therapeutic Agents to Small Animals

    Published on: March 30, 2017

    Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies
    08:33

    Use of Capillary Aerosol Generator in Continuous Production of Controlled Aerosol for Non-Clinical Studies

    Published on: April 12, 2022